بحث بيانات أعضاء هيئة التدريس - جامعة الزقازيق

/ بحث بيانات أعضاء هيئة التدريس - جامعة الزقازيق

لايوجد

الموقع الشخصى

امرالله عبدالمنعم محمد سيد

الكلية الطب - القسم طب الأورام

الدرجات العلمية

بكالوريوس فى الطب والجراحه, -جامعة الزقازيق [1997]
ماجستير فى الباطنه العامه, -جامعة الزقازيق [2002]
(تقييم عامل النمو للخلايا المبطنه للآوعية الدموية وعامل نمو الخلايا الليفيه القلوى فى مرضى أورام الغدد الليمفاوية والغير هودجيكين المقاومة العلاج والمنتكسة ومدى الاستجابه لبروتوكول "أى - سى - أى ".)
دكتوراه فى الباطنه العامه, -جامعة الزقازيق [2009]

الحالة الوظيفية الحالية :

قائم بالعمل

التدرج الوظيفى الأكاديمى

معيد : 2/2/2003
مدرس مساعد : 27/4/2003
مدرس : 31/8/2009
أستاذ مساعد : 27/3/2018
أستاذ : 28/3/2023

الأبحاث العلمية

1 - Impact of body mass index on clinico-pathological parameters and outcome in patients with metastatic prostate cancer (1436).

2 - Emergency Department Visits at the End of Life of Patients With Terminal Cancer: Pattern, Causes, and Avoidability (1436).

3 - The Relation Between the Timing of Palliative Care and the Frequency and Timing of Do-Not-Resuscitate Orders Among Cancer Deaths in a Tertiary Care Hospital (1436).

4 - End-of-life palliative chemotherapy: Where do we stand? (1436).

5 - For pathological response to neoadjuvant chemotherapy in hormonal receptors-positive breast cancer (1436).

6 - The pattern of infection and antibiotics use in terminal cancer patients (1435).

7 - Response of Triple Negative Breast Cancer to Neoadjuvant Chemotherapy: Correlation between Ki-67 Expression and Pathological Response. (1437).

8 - Correlation of preoperative Ki67 and CA15.3 levels with the outcome in early breast cancer:.A multi institutional study (1437).

9 - Urinary bladder cancer: biomarkers and target therapy, new era for more attention (1438).

10 - Advanced thyroid cancers: new era of treatment (1436).

11 - Biomarkers in prostate cancer: new era and prospective (1436).

12 - Paroxysmal Nocturnal Hemoglobinuria: From Bench to Bed (1437).

13 - Solid Pseudopapillary Tumor of the Pancreas: A Case Report (1435).

14 - Gastrointestinal obstruction in palliative care: a review (1436).

15 - Target therapy in metastatic pheochromocytoma: current perspectives and controversies (1435).

16 - Leptomeningeal metastasis from gastroesophageal carcinoma (1435).

17 - Genomic aberrations in non- small cell lung cancer and their impact on treatment outcome (1437).

18 - Pattern of Venous Thrombosis in Cancer Patients: Frequency and Survival Effect; Single Center Experience (1436).

19 - Triple Primary Carcinomas: Prostatic Adenocarcinoma, Bladder Urethral Carcinoma and Papillary Thyroid Carcinoma: A Case Report (1436).

20 - Double Primary Cancers Registered in Tertiary Care Hospital: Review of Cases (1435).

21 - Clinicopathological Features of Gastric Cancer; Single Center Experience (1435).

22 - Scope of management of nausea and vomiting in palliative car e: review (1435).

23 - Scope of management of emergencies in palliative care (1435).

24 - Advanced pancreatic cancer: The standard of care and new opportunities (1439).

25 - Myelodysplastic syndrome from theoretical review to clinical application view (1440).

26 - Patterns of Inpatient Admissions during Haj Clinical conditions, length of stay and patient outcomes at an advanced care centre in Makkah, Saudi Arabia (1439).

27 - Neoadjuvant Platinum and Gemcitabine Regimens Precede Definitive Radiotherapy in Locally Advanced Bladder Cancer (1440).

28 - Efficacy and Safety of First-Line Pazopanib in Patients with Metastatic Renal Cell Carcinoma: Real-Life Multi Institutional Experience (1440).

29 - ?Aggressive Care at the End of Life; Where Are We (1441).

30 - CDK4/6 inhibitors in advanced breast cancer, what is beyond? (1440).

31 - C-MYC and BCL2: Correlation between Protein Over-Expression and Gene Translocation and Impact on Outcome in Diffuse Large B Cell Lymphoma (1440).

32 - Patterns of emergency department visits during Hajj period: Towards healthcare optimization in view of Saudi Arabia’s vision 2030 (1440).

33 - Impact of cyclin D1 and DJ-1 on diagnosis, clinico-pathological features and outcome in prostate cancer and benign prostatic hyperplasia (1440).

34 - Neoadjuvant Chemotherapy in Triple Negative Breast Cancer: Correlation between Androgen Receptor Expression and Pathological Response (1442).

35 - Impact of Prognostic Nutritional Index on Terminal Cancer Patients (1442).

36 - Impact of vitamin D serum levels on clinicopathological features and outcome in advanced pancreatic carcinoma (1441).

37 - The effect of body mass index on clinico-pathological features and survival outcome in metastatic bladder carcinoma (1442).

38 - Low-Dose Cytarabine versus Best Supportive Care for Patients with Acute Myeloid Leukaemia Unfit for the Standard of Care: Egyptian Centre Experience (1442).

39 - Prediction of Survival Outcome Using Chuang’s Prognostic Scale in Metastatic Breast Cancer (1443).

40 - Evaluating the value of Amphiregulin, Phosphatase and Tensin Homologue (PTEN) and P21 Expression for Anti-EGFR Treatment in Metastatic Colorectal Carcinoma (1442).

41 - Impact of the Prognostic Nutritional Index on Quality of Life of Terminal Cancer Patients (1442).

42 - Metastatic Triple Negative Breast Cancer: The New Era of Thinking (1440).

43 - Predictive and Prognostic Value of Tumor- Infiltrating Lymphocytes for Pathological Response to Neoadjuvant Chemotherapy in Triple Negative Breast Cancer (1443).

المجالات البحثية